Zhuhai Rundu Pharmaceutical (002923.SZ): The hydrochloride of meperidine injection obtained the drug registration certificate.
Runthu Group (002923.SZ) announcement: The company has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the injection of methylergometrine maleate. This product is used for cardiac stress testing, suitable for myocardial perfusion imaging (MPI) to evaluate myocardial ischemia.
Zhuhai Rundu Pharmaceutical (002923.SZ) annonuced that the company has received the Drug Registration Certificate for the injection of Desmethyllevomilnacipran Hydrochloride issued by the National Medical Products Administration. This product is a drug used for cardiac load testing and is suitable for Myocardial Perfusion Imaging (MPI) to evaluate myocardial ischemia.
Related Articles

Industrial: Market fluctuations intensify. How are various types of funds moving?

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.
Industrial: Market fluctuations intensify. How are various types of funds moving?

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


